Investing.comQwen · 实盘不做把握 2/10不做原因:不是事件
北京时间·🕒 发布 20:04:35·⟳ 抓取 20:07:08 +2m33s·⚡ 决策 09-01 20:15:51 +8m43s·55.9 天前
QC Ware与IonQ展示基于Forte量子计算机的混合量子-经典药物发现化学工作流
这是一篇技术演示新闻稿，展示量子计算在药物发现化学建模中的能力。QC Ware为私有公司不可交易；唯一上市主体IonQ仅作为硬件平台被引用，演示不涉及商业合同、收入、客户采用或里程碑，属于常规能力展示类PR，不构成任何可交易的增量催化。Web/KB/行情查询不会改变此结论。
📄 原文Investing.com↗ 原文
QC Ware and IonQ test quantum workflow for drug discovery
Fed hike bets, oil rally and Japan yields - what’s moving markets PALO ALTO, Calif. - QC Ware announced today a demonst…
不做 IonQ（IONQ.US）
技术演示类PR，无商业合同、无收入、无客户采用里程碑；IonQ仅作为硬件平台被引用，不改变其收入或商业化前景，无正期望交易机会
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
QC Ware（私有）与IonQ联合发布技术演示PR，展示混合量子-经典工作流在药物发现酶建模中达到化学精度。事件无商业合同、无收入、无客户采用里程碑。QC Ware不可交易；IonQ的参与仅为硬件平台能力展示，不改变其收入或商业化前景。属于无交易意义的技术噪音。
🔎 新鲜度:最早出现 2026-09-01 · 扩散 low · price-in 风险 low ↗
先例如何影响了这次决策
对本次决策的影响:事件无交易意义，无需先例校准
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 2,293 ms
{"result": "search_processed_events:agent query=`ionq forte quantum computing chemistry workflow | promethium hybrid quantum classical cytochrome p450 | qc ware ionq quantum drug discovery`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 62.6/72 小时、2203 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是重复；按当前
原文全文
展开原文 · 2,128 字
Fed hike bets, oil rally and Japan yields - what’s moving markets
PALO ALTO, Calif. - QC Ware announced today a demonstration of a hybrid quantum-classical chemistry workflow using its Promethium platform and IonQ’s (NYSE:IONQ) Forte quantum computer via Amazon Braket.
The demonstration modeled the heme active site of cytochrome P450nor, an enzyme in the cytochrome P450 superfamily whose members carry out most human drug metabolism. The workflow calculated electrostatic interaction energy within 0.5 kcal/mol of classical benchmarks, falling inside the 1 kcal/mol threshold for chemical accuracy, according to a press release statement.
Promethium built and preprocessed a 115-atom model of the P450nor active site containing over 1,000 molecular orbitals. The system isolated the strongly correlated region to a 4-orbital active space mapped onto 8 qubits, which IonQ Forte measured before returning results for final energy computation.
"Running the same hybrid workflow on IonQ’s trapped-ion architecture, following our recent demonstration on other quantum hardware, shows that Promethium’s approach to combining classical and quantum computing is not tied to a single type of quantum hardware," said Dr. Kin-Joe Sham, Co-Founder and COO at QC Ware.
Scott Millard, Chief Business Officer at IonQ, stated that the companies "have shown that hybrid quantum-classical workflows can predict certain binding behavior accurately enough for discovery teams to confidently rank candidates and catch toxicity risks early."
The demonstration was supported in part by Amazon Web Services cloud compute credits. QC Ware stated that Promethium’s GPU-native architecture runs selected calculations up to 20 times faster than conventional CPU-based DFT platforms.
QC Ware develops quantum computing software applications for drug discovery and material design. IonQ provides quantum computing platforms and services available through major cloud providers since 2021. The company is headquartered in College Park, Maryland.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
PALO ALTO, Calif. - QC Ware announced today a demonstration of a hybrid quantum-classical chemistry workflow using its Promethium platform and IonQ’s (NYSE:IONQ) Forte quantum computer via Amazon Braket.
The demonstration modeled the heme active site of cytochrome P450nor, an enzyme in the cytochrome P450 superfamily whose members carry out most human drug metabolism. The workflow calculated electrostatic interaction energy within 0.5 kcal/mol of classical benchmarks, falling inside the 1 kcal/mol threshold for chemical accuracy, according to a press release statement.
Promethium built and preprocessed a 115-atom model of the P450nor active site containing over 1,000 molecular orbitals. The system isolated the strongly correlated region to a 4-orbital active space mapped onto 8 qubits, which IonQ Forte measured before returning results for final energy computation.
"Running the same hybrid workflow on IonQ’s trapped-ion architecture, following our recent demonstration on other quantum hardware, shows that Promethium’s approach to combining classical and quantum computing is not tied to a single type of quantum hardware," said Dr. Kin-Joe Sham, Co-Founder and COO at QC Ware.
Scott Millard, Chief Business Officer at IonQ, stated that the companies "have shown that hybrid quantum-classical workflows can predict certain binding behavior accurately enough for discovery teams to confidently rank candidates and catch toxicity risks early."
The demonstration was supported in part by Amazon Web Services cloud compute credits. QC Ware stated that Promethium’s GPU-native architecture runs selected calculations up to 20 times faster than conventional CPU-based DFT platforms.
QC Ware develops quantum computing software applications for drug discovery and material design. IonQ provides quantum computing platforms and services available through major cloud providers since 2021. The company is headquartered in College Park, Maryland.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。